CLINICAL_TRIALS
research
· 2025-10-02
Clinical Trial Update: Proof of Concept Study on Pitolisant Effect on Autism Spectrum Disorders in Children and Adolescents [Phase 2]
Summary
A Phase 2 proof-of-concept study is evaluating pitolisant for autism spectrum disorder in children and adolescents. The trial status is active but not recruitin…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bioprojet | Conditions: Autism Spectrum Disorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING